Inscrivez-vous pour créer des alertes relatives aux instruments,
aux événements économiques et au contenu publié par vos auteurs préférés
Inscription gratuite Vous avez déjà un compte ? Connexion
126,900
-0,870
-0,68%
Cotations
Tous types d’instruments
- Tous types d’instruments
- Indices
- Actions
- ETF
- Fonds
- Mat. prem.
- Devises
- Crypto
- Oblig.
- Certificats
Merci d'essayer une autre recherche
🍎 🍕 Moins de pommes, plus de pizza 🤔 Le point sur les dernières décisions de Buffett
Explorer gratuitement
Ubs (irl) Investor Selection - Equity Opportunity Long Short Fund Q-pf-acc (0P0000X6LO)
Ajouter au/Supprimer du portefeuille
Ajout au Portefeuille
21/11 - Fermé. Devise en EUR
- Rating de Morningstar:
- Actif total: 1,47M
Type:
Fonds
Marché:
Irlande
Emetteur:
UBS Fund Management (Luxembourg) S.A.
ISIN:
IE00B841P542
Catégorie d'actif:
Action
UBS (Irl) Investor Selection - Equity Opportunity
126,900
-0,870
-0,68%
Vue d'ensemble 0P0000X6LO
Sur cette page vous trouverez un profil détaillé de Ubs (irl) Investor Selection - Equity Opportunity Long Short Fund Q-pf-acc. Vous y trouverez notamment des informations sur la gestion, le total des actifs, la stratégie d'investissement et les coordonnées de 0P0000X6LO entre autres informations.
Actif total
1,47M
Dépenses
0,93%
Date de création
26/11/2012
Contact
Adresse
"1st Floor, College Park House, South Frederick Street"
Dublin,
Ireland
Dublin,
Ireland
Téléphone
-
Principaux dirigeants
| Nom | Titre | Depuis | Jusqu’à |
|---|---|---|---|
| Scott Wilkin | - | 2024 | Maintenant |
| Biographie | Scott is the Head of the Global Intrinsic Value Equity team and co-PM for our Global equity portfolios. He is also Director of Research (DOR); responsible for managing the 13-member analyst team and driving research quality standards across the Global Intrinsic Value platform. In 2012, Scott was promoted to the position of DOR for the US Intrinsic Value equity team. In this role, Scott managed a team of six sector-based analysts and lead company and industry-level research. Scott was also the lead portfolio manager of the Intrinsic Value equity team's Global Healthcare and UBS Healthcare Long/Short strategies. Prior to being named DOR and portfolio manager, Scott was a Senior Investment Analyst and Sector Head for the health care analyst team. His responsibilities included fundamental company and industry-level research. | ||
| Florian Töpfl | - | 2024 | Maintenant |
| Dimitrios Goumenos | - | 2024 | Maintenant |
| Jeremy Leung | - | 2010 | 2024 |
| Biographie | Jeremy Leung is Portfolio Manager on the Concentrated Alpha Equity team at UBS Asset Management. He is responsible for supporting the investment process and strategy communication for the team. Prior to undertaking his role in March 2011, Jeremy was a Quantitative Analyst within the Equities Group. He was responsible for conducting quantitative and fundamental research for the Group’s investment teams. He also worked extensively on the Group’s fundamental equity valuation model. Prior to joining UBS in 2007, Jeremy worked as a consultant for FactSet Research Systems. He was responsible for providing advice and support to large investment managers across Europe on various analytical tools for investing. Jeremy is a Regular Member of the CFA Society of the UK and the CFA Institute. | ||
| Maximilian Anderl | - | 2010 | 2024 |
| Biographie | Maximilian Anderl is Head of Concentrated Alpha Equity within UBS Asset Managment and is the lead portfolio manager for the Global and European Concentrated Alpha long only and long / short strategies. Maximilian has worked on the Concentrated Alpha team and its distinctive approach and strategies since its inception in 2004, becoming head of that team in January 2011. Maximilian joined the European Equity Team in London in 2002, having joined UBS Asset Management, Zurich, in 2000 as an equity fund manager. In that role he was responsible for the retail funds and European client mandates. Prior to joining UBS, Maximilian worked in academic research, university teaching, research and development and corporate finance for the pharmaceutical industry. Maximilian is a Regular Member of the CFA Society of the UK and the CFA Institute. | ||
| Marc Schaffner | - | 2017 | 2019 |
| Biographie | Marc Schaffner is part of the Investment Solutions team, where he is responsible for implementing strategy decisions taken by the Swiss Investment Committee into client portfolios. He is also a member of the Multi-Asset Investment Committee in his role as senior investment strategist for Switzerland and EMEA across client segments. Prior to joining UBS in 2001, Marc worked for a smaller company doing asset management on a fund basis. He was responsible for a Hedge Fund of Funds and was involved in the fund selection and the asset allocation process of various other portfolios. Marc is a member of the Swiss Investment Committee in Zurich. | ||
Exprimez-vous à propos de Ubs (irl) Investor Selection - Equity Opportunity Long Short Fund Q-pf-acc
Êtes-vous sûr de vouloir supprimer ce graphique ?
Supprimer Annuler
Remplacer le graphique actuel par un nouveau graphique?
Remplacer Annuler
Charte de discussion
Ajouter un graphique au commentaire
Confirmer le blocage
Voulez-vous vraiment bloquer %USER_NAME% ?
Si vous continuez, vous et %USER_NAME% ne verrez plus vos publications Investing.com mutuelles.
%USER_NAME% a bien été ajouté à votre Liste d’utilisateurs bloqués
Vous venez de débloquer cette personne et devrez attendre 48 heures avant de la bloquer de nouveau.
Signaler ce commentaire comme inapproprié
Je souhaite signaler ce commentaire comme:
Commentaire signalé
Merci
Le commentaire signalé sera révisé par nos modérateurs